Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia.

TitleCross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia.
Publication TypeJournal Article
Year of Publication2020
AuthorsOuellette AR, Neuner SM, Dumitrescu L, Anderson LC, Gatti DM, Mahoney ER, Bubier JA, Churchill G, Peters L, Huentelman MJ, Herskowitz JH, Yang H-S, Smith AN, Reitz C, Kunkle BW, White CC, De Jager PL, Schneider JA, Bennett DA, Seyfried NT, Chesler EJ, Hadad N, Hohman TJ, Kaczorowski CC
Corporate AuthorsAlzheimer’s Disease Genetics Consortium
JournalCell Rep
Volume32
Issue9
Pagination108091
Date Published09/2021
ISSN2211-1247
KeywordsAge Factors, Alzheimer Disease, Black or African American, Cognitive Dysfunction, Dementia, Female, Genome-Wide Association Study, Humans, Male, Middle Aged, Nerve Tissue Proteins, Species Specificity
Abstract

Genetic mechanisms underlying age-related cognitive decline and dementia remain poorly understood. Here, we take advantage of the Diversity Outbred mouse population to utilize quantitative trait loci mapping and identify Dlgap2 as a positional candidate responsible for modifying working memory decline. To evaluate the translational relevance of this finding, we utilize longitudinal cognitive measures from human patients, RNA expression from post-mortem brain tissue, data from a genome-wide association study (GWAS) of Alzheimer's dementia (AD), and GWAS results in African Americans. We find an association between Dlgap2 and AD phenotypes at the variant, gene and protein expression, and methylation levels. Lower cortical DLGAP2 expression is observed in AD and is associated with more plaques and tangles at autopsy and faster cognitive decline. Results will inform future studies aimed at investigating the cross-species role of Dlgap2 in regulating cognitive decline and highlight the benefit of using genetically diverse mice to prioritize novel candidates.

DOI10.1016/j.celrep.2020.108091
Alternate JournalCell Rep
PubMed ID32877673
PubMed Central IDPMC7502175
Grant ListP30 AG038070 / AG / NIA NIH HHS / United States
P50 DA039841 / DA / NIDA NIH HHS / United States
U24 AG021886 / AG / NIA NIH HHS / United States
R01 AG054719 / AG / NIA NIH HHS / United States
P50 AG008702 / AG / NIA NIH HHS / United States
R01 AG054180 / AG / NIA NIH HHS / United States
R01 AG017917 / AG / NIA NIH HHS / United States
F31 AG050357 / AG / NIA NIH HHS / United States
RF1 AG054080 / AG / NIA NIH HHS / United States
U01 AG061357 / AG / NIA NIH HHS / United States
P30 AG066462 / AG / NIA NIH HHS / United States
R01 AG059716 / AG / NIA NIH HHS / United States
K23 AG062750 / AG / NIA NIH HHS / United States
R01 AG064614 / AG / NIA NIH HHS / United States
K01 AG049164 / AG / NIA NIH HHS / United States
RF1 AG057470 / AG / NIA NIH HHS / United States
R01 AG015819 / AG / NIA NIH HHS / United States
R01 AG057914 / AG / NIA NIH HHS / United States
RF1 AG057471 / AG / NIA NIH HHS / United States
R01 AG061800 / AG / NIA NIH HHS / United States
RF1 AG062181 / AG / NIA NIH HHS / United States
U01 AG061356 / AG / NIA NIH HHS / United States
U01 AG032984 / AG / NIA NIH HHS / United States
F31 MH067445 / MH / NIMH NIH HHS / United States
R01 AG036042 / AG / NIA NIH HHS / United States
P30 AG010161 / AG / NIA NIH HHS / United States
U01 AG052410 / AG / NIA NIH HHS / United States
RF1 AG063755 / AG / NIA NIH HHS / United States